Viewing Study NCT02688361


Ignite Creation Date: 2025-12-24 @ 12:19 PM
Ignite Modification Date: 2026-01-21 @ 3:58 PM
Study NCT ID: NCT02688361
Status: COMPLETED
Last Update Posted: 2019-01-24
First Post: 2016-02-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral Solution
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module